A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...

AJMC®: What recent developments in the therapeutic landscape of chronic obstructive pulmonary disease (COPD) do you think have the greatest potential to shift how treatment is managed? Dr Martinez: ...

In one of the priciest health care deals of 2025, the pharmaceutical giant Merck has acquired the British drugmaker Verona Pharma, which has its U.S. headquarters in Raleigh, for roughly $10 billion.

Merck’s Maurice R. Hilleman Center for Vaccine Manufacturing photographed on Friday, Apr. 2, 2021, in Durham, N.C. Casey Toth ctoth@newsobserver.com In one of the biggest health care deals of 2025, ...

CINCINNATI — A 75-year-old Florence woman told us she thought her severe COPD was a life sentence. Until, that is, she discovered a breakthrough treatment that has transformed her daily life. Mary Kay ...

Using a care pathway focused on chronic obstructive pulmonary disease (COPD) can lead to shorter hospital stays, increased referrals to pulmonary rehabilitation, and improved standardization of care, ...

In one of the biggest health care deals of 2025, the pharmaceutical giant Merck has acquired the British drugmaker Verona Pharma for roughly $10 billion. Merck announced its purchase of the publicly ...